Stoke Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
STOK
CUSIP
86150R107
Type
Equity
Class
COM
Num filers
185
Total reported value, excl. options
$1.92B
Manager Report Date Value ($000) Shares